Lv11
44 积分 2023-07-28 加入
Comparative efficacy and safety of faricimab, aflibercept, conbercept, and ranibizumab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
1天前
已完结
Treatment Patterns and Long-Term Outcomes with Anti–VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database
16天前
已完结
Treatment discontinuation patterns of anti-vascular endothelial growth factor in retinal vein occlusion
16天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
24天前
已完结
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study
25天前
已完结
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society
1个月前
已完结
Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?
1个月前
已完结
Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer
1个月前
已完结
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC
1个月前
已完结
Targeting ALK receptors in non-small cell lung cancer: what is the road ahead?
1个月前
已完结
皖公网安备34019202002308
